Ross Warshauer
Analista di Private Equity presso 3i US
Profilo
Ross Warshauer is currently working as an Associate at 3i US since 2021.
Prior to this, he worked as a Director at ten23 Health AG.
Mr. Warshauer completed his undergraduate degree from Goizueta Business School-Emory in 2019.
Posizioni attive di Ross Warshauer
| Società | Posizione | Inizio |
|---|---|---|
3i US
 3i US Investment ManagersFinance 3i U.S. is a venture capital firm headquartered in Menlo Park, California. The firm is a subsidiary of 3i Group Plc (LSE: III). | Analista di Private Equity | 01/09/2021 |
Precedenti posizioni note di Ross Warshauer
| Società | Posizione | Fine |
|---|---|---|
ten23 Health AG
 ten23 Health AG BiotechnologyHealth Technology ten23 Health AG, founded in 2021, is a Swiss pharmaceutical company that specializes in designing, characterizing, and validating the manufacturing process for stability and preclinical purposes. The company is based in Basel, Switzerland, and has subsidiaries in Switzerland. The company is the partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow ’ s medicines. The company's team of experts can test and evaluate the stability of a vast range of therapeutic modalities. | Direttore/Membro del Consiglio | - |
Formazione di Ross Warshauer
| Goizueta Business School-Emory | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
3i US
3i US Investment ManagersFinance 3i U.S. is a venture capital firm headquartered in Menlo Park, California. The firm is a subsidiary of 3i Group Plc (LSE: III). | Finance |
ten23 Health AG
ten23 Health AG BiotechnologyHealth Technology ten23 Health AG, founded in 2021, is a Swiss pharmaceutical company that specializes in designing, characterizing, and validating the manufacturing process for stability and preclinical purposes. The company is based in Basel, Switzerland, and has subsidiaries in Switzerland. The company is the partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow ’ s medicines. The company's team of experts can test and evaluate the stability of a vast range of therapeutic modalities. | Health Technology |
- Borsa valori
- Insiders
- Ross Warshauer
